For this reason, we focused on the relationship between blood GFAP and AD and aimed to evaluate GFAP in the peripheral blood as a biomarker for AD by conducting a systematic review and meta-analysis and discussing the possibility of GFAP as an AD blood biomarker. This evidence concerns the gene GFAP and Alzheimer disease.